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ABSTRACT
The study aimed to determine whether impedance cardiography-based stroke volume (SV)
measurements could be used in optimizing the atrioventricular (AV) interval for dual-chamber pacemakers in patients with preserved AV conduction. The study included 42 consecutive patients (33
males; mean age, 66.8 ± 7.7 years) indicated for a dual-chamber pacemaker or dual-chamber defibrillator. SV was evaluated during intrinsic AV conduction and sequential AV pacing 4 ± 2 days after
implantation by using impedance cardiography. During intrinsic AV node conduction, the mean PQ
time was 205 ± 61.9 ms. The mean optimal AV delay in the DDD mode was 103 ± 25 ms. The mean
SV was 65.8 ± 14.0 ml during intrinsic conduction and increased to 73.6 ± 14 ml (P < 0.001) after
optimizing the AV interval. The mean increase in SV during optimal AV delay was 17 ± 17% in
patients with prolonged AV conduction versus 6 ± 5% in patients with normal AV conduction. Dualchamber pacing without optimizing AV delay may impair hemodynamics (65.8 ± 14.0 ml for the
mean SV of the hemodynamically worst AV delay vs. 61.7 ± 11.7 ml for the mean SV of the intrinsic
AV conduction; P = 0.001). AV optimizing in patients with a baseline PQ interval of <160 ms did
not improve hemodynamics. In patients with dual-chamber pacemakers and a baseline PQ-interval
of ≥160 ms, optimizing the AV interval significantly improved the SV. Blindly programming AV
delay may be harmful through impairing the hemodynamics.
Keywords: Dual-chamber pacing, Optimization of atrioventricular delay, Impedance cardiography.
INTRODUCTION
Optimal atrioventricular delay (AVD) is
critical for cardiac hemodynamics in patients
with dual-chamber pacemakers, especially for
an appropriately timed atrial systole and an increase in the end-diastolic left ventricular
(LV) volume [1-6]. The optimal AVD appears
to be determined by a number of cardiac (i.e.,
hemodynamic and electrophysiological) factors [7-10]. A number of methods has been
used to investigate the effects of different
AVDs on left atrial and ventricular function,
but most are complicated, invasive, or too expensive for clinical routine. Impedance cardiography (IC) and Doppler echocardiography
are 2 non-invasive methods for determining
the optimal AVD in patients with dual-chamber or atrial-triggered ventricular pacing [2,
11, 12]. However, a disadvantage of echocardiography is that this method is time consuming [13, 14].

Several studies have compared IC with
other methods, such as the rmodilution, the indirect Fick (CO2) method, and radionuclide
ventriculography, and found a good correlation in the results between them [15-18]. IC
measurements show a high reproducibility
and allow the reliable detection of small
changes in stroke volume (SV) at various
pacemaker settings [19]. Moreover, prior
studies have demonstrated that IC was a useful, non-invasive technique for optimizing the
AVD and correlated well with Doppler echo
in patients with standard DDD pacemakers [3,
11, 19-22]. Uncontrolled studies have shown
that symptomatic patients with a PR interval
of ≥300 ms and normal LV function improved
with dual-chamber pacing; the improvement
in this group of patients is considered a Class
IIa indication for permanent pacing [23, 24].
When comparing AAI and DDD modes of
pacing in patients with sick sinus syndrome, a
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normal ejection fraction, and a long PR interval, a previous study found that patients with
an AV interval of <270 ms and >270 ms had a
higher aortic velocity time integral with AAI
pacing and DDD pacing, respectively [25].

effects of atrial pacing on the AV interval
[28]. During data acquisition, the telemetry
between the implanted device and the programmer was disconnected to prevent interference with the measurement of impedance.

The best method for programming AVD
in patients with preserved intrinsic AV conduction in the absence of a high degree AV
block is still debated. Further, the data conflict
on whether intrinsic AV conduction should be
preserved in patients paced with a dual-chamber pacemaker in the absence of a high degree
AV block [25]. The aim of the current study
was to determine whether IC-based SV measurements could be used in optimizing the AV
interval in pacemakers for patients with preserved intrinsic AV conduction and in detecting immediate hemodynamic changes with
optimized AV delay versus no ventricular
pacing.

Impedance cardiography

METHODS
Patients
Forty-two consecutive patients (33 males;
mean age, 66.8 ± 7.7 years) with an indication
for dual-chamber pacemakers or dual-chamber defibrillators according to current guidelines [26, 27] and sinus rhythm were included
in this study between February 2004 and
March 2005. The baseline characteristics of
the study patients are detailed in Table 1.
Evaluation of patients before implantation included a 12-lead surface electrocardiography,
as well as echocardiography for measurements of the LV dimensions and LVEF in the
apical 4-chamber view.
Device implantation
Dual-chamber pacemakers or dual-chamber defibrillators were implanted using the
standard techniques, with atrial and ventricular electrodes positioned at the right appendage and right ventricular apex, respectively.
Pacing study protocol
For optimizing the AVD, all patients
were examined in the supine position in a silent environment to reduce the impact of sympathetic activation by external stimuli. A
standard protocol involving a period of stabilization and equilibration was performed.
Pacemakers were programmed in DDD mode
with a lower rate limit of 30 bpm to avoid the

The optimization of AVD was performed
using a commercially available system for IC
(Task Force Monitor Systems, CN Systems,
Graz, Austria). Two electrodes were placed
bilaterally to the inferior chest wall in combination with 1 electrode at the neck. A low-amplitude, high-frequency current was delivered
via these surface electrodes, and transthoracic
impedance (resistance) to this current flow
was measured. Changes in transthoracic impedance were measured by means of 4 additional surface electrodes: one pair was placed
bilaterally to the sternum, and the second pair
was placed bilaterally to the abdomen. SV was
calculated on a beat-to-beat basis from the
transthoracic impedance signal [29]. SV was
measured during intrinsic conduction (VVI
mode at 30 beats/min) and AV pacing using a
standard protocol. The AV-interval modification involved changes from 80 to 120 ms, in
20-ms steps, and a nominal AV interval of 150
ms. Once the consistent values for SV were
confirmed, we proceeded to the next stage of
the AV interval in the pacing protocol.
Informed consent
This trial was a prospective one in which
all patient had implanted pacemaker. The patients provided informed consent and approval
for the study. The study added no harm to the
patients either physiologically or psychologically rather than the disease itself. Management was given to them according to the
guidelines and standard safety measures.
Statistics
All data are expressed as the mean value
± standard deviation. Statistical analysis was
performed using Fisher’s exact test comparing
more than 2 sets of data. For comparison between 2 sets of data, a student’s t-test was
used. A P-value of less than 0.05 was considered to be significant. Data processing was
done using commercially available software
(SPSS version 16.0).
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RESULTS
Patients characteristics involved in the
study were analyzed and showed that most of
them were females (33 females compared to 9

males), with mean age 66.8 years, 59% of
them had coronary artery disease (CAD) at
baseline, with mean left ventricular ejection
fraction (LVEF) 44.8. Detailed characteristics
of the patients are shown in Table 1.

Table (1): Patient characteristics.
Characteristic
Age (years)
Gender (female/male)
%CAD
QRS (ms)
PQ (ms)
LVEF %

Mean ± standard deviation
66. 8 ± 7.7
33/9
59
96.2 ± 30.5
205.8 ± 61.9
44.8 ± 16.6

CAD: Coronary artery disease, LVEF: Left ventricular ejection fraction

The mean baseline PQ interval and mean
QRS duration during intrinsic AV node conduction were 205 ± 61.9 ms and 96.3 ± 30 ms,
respectively. The mean optimal AV delay was
103 ± 25 ms. The mean SV increased from

65.8 ± 14 ml during intrinsic conduction to
73.6 ± 14 ml after optimization of the AVD
interval (P < 0.001; Figure 1).

Figure (1): Increase in stroke volume (ml) by intrinsic atrioventricular (AV) node conduction following the use of optimal AV delay measured by impedance cardiography at rest.
than the SV during intrinsic AV conduction
This increase in SV during optimal AVD
(61.7 ± 11.7 ml vs. 65.8 ± 14.0, respectively;
was observed in patients with normal and proP = 0.001; Figure 2).
longed AV conduction. In patients with normal AV conduction, the mean SV during intrinsic AV conduction was 71.0 ± 14.8 ml vs.
76 ± 15 ml after optimizing the AVD (P =
0.002). In patients with prolonged AV node
conduction, the mean SV during intrinsic AV
conduction was 60.4 ± 11.0 ml vs. 71. ± 12 ml
after optimizing the AVD (P < 0.0001). However, the worst SV during differently paced
AVDs (80–120 ms and 150 ms) was lower
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Figure (2): Stroke volume measured by impedance cardiography without ventricular pacing in comparison to SV for the worst AV delay.
normal AV conduction (<200 ms; 21 patients;
Patients with prolonged AV conduction
mean PQ time, 157.4 ± 16.1 ms). The mean
(≥200 ms; 21 patients; mean PQ time, 249.5 ±
SV was 60.4 ± 11.0 ml and 71.0 ± 14.8 ml in
45.7 ms) had a significantly lower SV during
this former and latter groups, respectively (P
intrinsic AV conduction than patients with
= 0.014, Table 2).
Table (2): Hemodynamic parameters for optimal AVD and intrinsic AV node conduction.

All Patients
PQ-Time ≥ 200 ms
PQ-Time < 200 ms
PQ-Time ≥ 160 ms
PQ-Time < 160 ms
QRS ≥ 120 ms
QRS < 120 ms
LVEF ≥ 50%
LVEF < 50%

SV (ml) with AV intrinsic
conduction
65.8 ± 14
60.4 ± 11.0
71.0 ± 14.8
62.4 ± 12.5
76 ± 14
64.0 ± 12.4
66.4 ± 14.6
66.3 ± 17
65.5 ± 11.4

SV (ml) with optimal
AV Delay
73.6 ± 14
71 ± 12
76 ± 15
72 ± 13.6
78.7 ± 14.8
75.7 ± 9.0
73 ± 15.4
74.4 ± 16.8
73 ± 11.8

P value
<0.001
<0.0001
0.002
< 0.0001
0.1
0.01
<0.0001
0.004
< 0.001

SV (stroke volume), LVEF (left ventricular ejection fraction)

The optimization of the AVD increased
the SV in patients with normal and prolonged
AV conduction (6 ± 5% vs. 17 ± 17%), with
the effect more pronounced in the latter group
of patients. In the sub-analysis, we found that
patients with a PQ time of <160 ms (mean PQ
time, 145 ± 11.5 ms, 10 patients) did not benefit from optimizing the AVD interval (mean
SV by intrinsic AV node conduction, 76 ± 14
ml; mean SV by AVD optimization, 78.7 ±
14.8 ml). Optimization of the AV interval significantly improved the SV in patients with
bundle branch block (11 patients; mean QRS

duration, 139 ± 17 ms), as well in patients with
short QRS duration (mean QRS, 81 ± 16.3
ms). The mean SV at the baseline in patients
with bundle branch block was 64 ± 12.4 ml
and increased significantly to 75.7 ± 9 ml during AVD (P < 0.0001). Meanwhile, the mean
SV in patients with the short QRS was 66.4 ±
14.6 ml and increased to 73 ± 15.4 ml during
AVD (P = 0.01).
The mean SV during intrinsic AV conduction was 66.3 ± 17.1 ml in patients with a
preserved LV ejection fraction (LVEF) (19
patients; mean EF, 61.2 ± 6.2%) and 65.5 ±
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11.4 ml in patients with impaired LVEF (23
patients; EF, 31.3 ± 7.9). After optimization of
the AV interval, the SV was significantly increased to 74.4 ± 16.8 ml and 73 ± 11.8 ml,
respectively (P = 0.004 and P < 0.001, respectively).
DISCUSSION
Hemodynamic measurements 4 ± 2 days
after pacemaker implantation demonstrated
the hemodynamic benefit of optimizing the
AVD. The present study showed that patients
with prolonged AV conduction (≥200 ms) had
a significantly lower SV than patients with
normal AV conduction (<200 ms). This hemodynamic effect with a first AV block has been
shown in many previous studies [23] and is associated with exercise intolerance and shortness of breath due to early atrial contraction
before complete atrial filling, which leads to a
compromising of ventricular filling, an increase in pulmonary capillary wedge pressure,
and a decrease in cardiac output follow. This
electrical and mechanical remodeling may
lead to atrial fibrillation and other atrial arrhythmias. In our study, the SV during the optimal AV interval improved significantly from
baseline measurements in patients with AV
prolongation. In agreement with our results, a
number of studies previously demonstrated
improvement in acute cardiac function using
DDD pacing compared to AAI pacing with a
first degree AV block [25]. Lliev et al. [14]
demonstrated that AV interval optimization at
a shorter value that forced ventricular pacing
was associated with better cardiac performance as compared to normal ventricular activation. Over the past years, there has been a
trend to program very long AVDs to achieve
functional AAI pacing, even in the presence of
a marked first-degree AV block. This trend is
based on the results of the DAVID study [24]
and a number of other prospective studies
(MOST [25], MADIT II [26], Midas 6 [27].
These studies revealed that forced ventricular
pacing in the DDD group had resulted in left
bundle branch blocks contributing to an increased incidence of congestive heart failure.
However, in our study, we found that the optimization of AVD in patients with normal AV
conduction (only when AV conduction was
≥160 ms) was associated with significant increase in SV in comparison to their intrinsic

AV conduction. Although unnecessary ventricular pacing should be avoided, not all ventricular pacing, even from the RV apex, is automatically bad. The INTRINSIC RV trial
demonstrated that DDD pacing with AV hysteresis was superior to intrinsic conduction
with VVI at a standby rate of 40 bpm [22]. In
the Danpace study, single-chamber pacing
was compared with dual-chamber pacing
(DDD) in patients with sick sinus syndrome,
and was associated with an increased risk of
atrial fibrillation when the PQ interval was
>180 ms [28]. In agreement with the Danpace
trial, our study showed that DDD pacing with
an optimization of AV delay was superior to
intrinsic conduction when the PQ interval was
>160 ms with ventricular pacing showing abnormal ventricular activation sequence.
A major limitation in our study is that we
studied only the acute hemodynamic effect
but without long-term follow-up. We recommend long-term follow up after AV optimization to avoid deleterious effects of RV apex
pacing on myocardial function and to re-establish intrinsic AV conduction by deterioration of LV systolic function. Another potential
limitation is that IC can overestimate SV if
very short AV intervals are programmed [30].
In our study, we tried to overcome this limitation by programming an AVD of not less than
80 ms.
CONCLUSIONS
In this study, we found that the optimization of AV delay using IC is possible and resulted in significant improvement in acute hemodynamics compared to intrinsic AV conductions, not only in patients with markedly
prolonged PR interval but also in those with
normal AV conduction when the PQ time was
<160 ms with ventricular pacing showing abnormal ventricular activation sequence. We
add that blindly programming AVD pacing
without optimization of the AV interval may
impair the hemodynamics. The mean optimal
AV delay in the DDD mode was 103 ± 25 ms.
The increase in the mean SV was greater in
patients with a prolonged AV interval greater
than in those with a normal AV interval.
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